Michael DesJardin
Chief Tech/Sci/R&D Officer presso HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Posizioni attive di Michael DesJardin
Società | Posizione | Inizio | Fine |
---|---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/02/2017 | - |
Storia della carriera di Michael DesJardin
Precedenti posizioni note di Michael DesJardin
Società | Posizione | Inizio | Fine |
---|---|---|---|
RAPTOR PHARMACEUTICAL CORP | Chief Tech/Sci/R&D Officer | 01/04/2015 | 01/10/2016 |
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/07/2004 | 01/03/2015 |
ALZA CORPORATION | Chief Tech/Sci/R&D Officer | 01/01/1995 | - |
Formazione di Michael DesJardin
University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Irlanda | 3 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
Aziende private | 3 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
- Borsa valori
- Insiders
- Michael DesJardin
- Esperienza